Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Common Equity (2023 - 2025)

Haoxi Health Technology has reported Common Equity over the past 3 years, most recently at $17.4 million for Q2 2025.

  • Quarterly results put Common Equity at $17.4 million for Q2 2025, up 54.16% from a year ago — trailing twelve months through Jun 2025 was $17.4 million (up 54.16% YoY), and the annual figure for FY2025 was $17.4 million, up 54.16%.
  • Common Equity for Q2 2025 was $17.4 million at Haoxi Health Technology, up from $11.3 million in the prior quarter.
  • Over the last five years, Common Equity for HAO hit a ceiling of $17.4 million in Q2 2025 and a floor of $1.6 million in Q2 2023.
  • Median Common Equity over the past 3 years was $11.3 million (2024), compared with a mean of $10.1 million.
  • Biggest five-year swings in Common Equity: skyrocketed 619.56% in 2024 and later soared 54.16% in 2025.
  • Haoxi Health Technology's Common Equity stood at $1.6 million in 2023, then skyrocketed by 619.56% to $11.3 million in 2024, then soared by 54.16% to $17.4 million in 2025.
  • The last three reported values for Common Equity were $17.4 million (Q2 2025), $11.3 million (Q2 2024), and $1.6 million (Q2 2023) per Business Quant data.